Capstone Investment Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History

Capstone Investment Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-67,014	Closed	-$4.01M	–	1457
2019 Q4	$4.01M	Buy	+67,014	New	+$2.52M	0.02%	640

Capstone Investment Advisors's BOLD Position: Q1 2020 in Review

Capstone Investment Advisors sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 67,014 shares — an estimated $4.01M sold.

Capstone Investment Advisors first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $4.01M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Capstone Investment Advisors reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Capstone Investment Advisors sold 67,014 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $4.01M.
Capstone Investment Advisors first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Capstone Investment Advisors's Audentes Therapeutics, Inc position peaked at $4.01M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Capstone Investment Advisors's 13F filing for Q1 2020, filed 15 May 2020.